NASDAQ · Medical - Healthcare Information Services

Scienture Holdings, Inc. (SCNX) Stock

$3.76 -2.59% NASDAQ: SCNX Healthcare

Valuation

MetricValue
Price$3.76
Market Cap$6.11M
P/E Ratio-0.08
P/B Ratio0.09
P/S Ratio7.34
EPS (TTM)$-2.70
52-Week High$65.00
52-Week Low$0.13
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-53.51%
ROA-43.26%
ROCE-16.20%
Gross Margin95.48%
Operating Margin-27.19%
Net Margin-73.75%
Debt/Equity0.17
Current Ratio2.89

Annual Financials (USD)

Metric20212022202320242025
Revenue$10.0M$10.0M$1.0M$0$0
Operating Profit$-5.0M$-3.0M$-4.0M$-15.0M$-16.0M
Net Profit$-5.0M$-3.0M$-18.0M$9.0M$-42.0M
EPS$-245.00$-153.75$-187.25$62.00$-67.50
Op Margin-53.5%-28.4%-322.4%-10758.7%-3763.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$4.0M$13.0M$105.0M$84.0M
Total Liabilities$2.0M$3.0M$12.0M$26.0M$14.0M
Cash$3.0M$1.0M$0$0$7.0M
Borrowings$1.0M$2.0M$7.0M$4.0M$0

Latest News

SCIENTURE Announces Commercial Inventory Readiness and July Shipments of REZENOPY™ (naloxone hydrochloride) to Wholesalers GlobeNewswire · Jul 9, 2026 SCIENTURE Expands Arbli™ Payor Coverage and Commercial Access, Adding Approximately 12.5 Million Covered Lives Nationwide GlobeNewswire · Jun 18, 2026 SCIENTURE Secures Formulary Coverage for REZENOPY™ with a Large National Health Plan and Expands Commercial Team GlobeNewswire · Jun 9, 2026 EXCLUSIVE: Scienture Expands Coverage For Opioid Overdose Treatment Ahead Of Commercial Launch Benzinga · Jun 9, 2026 SCIENTURE to Present at The Small Cap Showcase & WTR Insights on June 9, 2026, in NYC ACCESS Newswire · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-3.0M$-2.0M$-2.0M$-14.0M$-13.0M
Investing Cash Flow$0$0$0$28.0M$0
Financing Cash Flow$0$0$1.0M$-1.0M$0
Net Cash Flow$-3.0M$-2.0M$-1.0M$0$6.0M
Free Cash Flow$-3.0M$-2.0M$-2.0M$-14.0M$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.01
EV / EBITDA-0.24
FCF Yield-239.49%
Quick Ratio2.97
Interest Coverage-4.48
Return 1Y-76.14%
Return 3Y-93.74%
Return 5Y-99.14%

Ownership

Insiders Held13.31%
Institutions Held3.87%
Institutions Float Held4.46%
Institutional HolderSharesReport Date
Geode Capital Management, LLC432,1862026-03-31
Vanguard Capital Management LLC408,0912026-03-31
Vanguard Fiduciary Trust Co198,0602026-03-31
UBS Group AG107,8332026-03-31
Virtu Financial LLC84,2112026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $336.64 -1.11% 38.93 $4.94T 0.32%
MSFTMicrosoft Corporation $535.07 +2.38% 28.68 $3.97T 0.76%
GOOGLAlphabet Inc. $351.66 +0.97% 16.94 $4.26T 0.26%
AMZNAmazon.com, Inc. $262.43 +3.29% 19.82 $2.82T 0.00%
METAMeta Platforms, Inc. $718.67 -0.31% 27.93 $1.83T 0.28%

About Scienture Holdings, Inc.

Scienture Holdings, Inc. is led by CEO Shankar Hariharan, employs 14 people, headquartered in US, publicly traded since 2014.

Scienture Holdings, Inc. (SCNX) stock trades at $3.76 with a market capitalization of $6.11M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.08, reflecting a net loss over the last twelve months, price-to-book of 0.09, price-to-sales of 7.34. Over the past 52 weeks the stock has ranged between $0.13 and $65.00, and currently trades 94.2% below its 52-week high.

On profitability, Scienture Holdings, Inc. generates a return on equity (ROE) of -53.51% (negative, reflecting a net loss), return on capital employed of -16.20%, an operating margin of -27.19%, a net profit margin of -73.75%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.